Molecular genetics of Alzheimer's disease: the role of beta-amyloid and the presenilins - PubMed (original) (raw)

Review

Molecular genetics of Alzheimer's disease: the role of beta-amyloid and the presenilins

A Tandon et al. Curr Opin Neurol. 2000 Aug.

Abstract

Alzheimer's disease is the most common neurodegenerative disorder of aging, accounting for an estimated two-thirds of all cases of senile dementia. Epidemiologic studies have failed to resolve any single cause of Alzheimer's disease and suggest a complex etiology, with environmental and genetic factors influencing the pathogenesis. Although the majority of cases are sporadic, a small number display familial clustering. Genetic analyses of these pedigrees have identified four genes that are involved in the development of Alzheimer's disease.

PubMed Disclaimer

Similar articles

• Alzheimer's disease: identification of genes and genetic risk factors.
  Van Broeckhoven C. Van Broeckhoven C. Prog Brain Res. 1998;117:315-25. doi: 10.1016/s0079-6123(08)64024-8. Prog Brain Res. 1998. PMID: 9932417 Review. No abstract available.
• Amyloid beta-protein and the genetics of Alzheimer's disease.
  Selkoe DJ. Selkoe DJ. J Biol Chem. 1996 Aug 2;271(31):18295-8. doi: 10.1074/jbc.271.31.18295. J Biol Chem. 1996. PMID: 8756120 Review. No abstract available.
• [Recent advances in the studies on Alzheimer's diseases].
  Tsuji S. Tsuji S. Rinsho Shinkeigaku. 1998 Dec;38(12):983-7. Rinsho Shinkeigaku. 1998. PMID: 10349334 Review. Japanese.
• Genetics of Alzheimer's disease.
  Hutton M, Pérez-Tur J, Hardy J. Hutton M, et al. Essays Biochem. 1998;33:117-31. doi: 10.1042/bse0330117. Essays Biochem. 1998. PMID: 10488446 Review.
• Molecular genetics of Alzheimer's disease.
  Goate AM. Goate AM. Geriatrics. 1997 Sep;52 Suppl 2:S9-12. Geriatrics. 1997. PMID: 9307578 Review.

Cited by

• The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.
  Abdullah L, Crawford F, Tsolaki M, Börjesson-Hanson A, Olde Rikkert M, Pasquier F, Wallin A, Kennelly S, Ait-Ghezala G, Paris D, Hendrix S, Blennow K, Lawlor B, Mullan M. Abdullah L, et al. Front Neurol. 2020 Mar 6;11:149. doi: 10.3389/fneur.2020.00149. eCollection 2020. Front Neurol. 2020. PMID: 32210906 Free PMC article.
• Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?
  Van Dam D, Vermeiren Y, Dekker AD, Naudé PJ, Deyn PP. Van Dam D, et al. Curr Alzheimer Res. 2016;13(10):1145-64. doi: 10.2174/1567205013666160502123607. Curr Alzheimer Res. 2016. PMID: 27137218 Free PMC article. Review.
• The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
  Watanabe K, Uemura K, Asada M, Maesako M, Akiyama H, Shimohama S, Takahashi R, Kinoshita A. Watanabe K, et al. Mol Brain. 2015 Dec 4;8(1):82. doi: 10.1186/s13041-015-0174-2. Mol Brain. 2015. PMID: 26637371 Free PMC article.
• Clinical, biological, and imaging features of monogenic Alzheimer's Disease.
  Pilotto A, Padovani A, Borroni B. Pilotto A, et al. Biomed Res Int. 2013;2013:689591. doi: 10.1155/2013/689591. Epub 2013 Nov 27. Biomed Res Int. 2013. PMID: 24377094 Free PMC article. Review.
• The role of the innate immune system in Alzheimer's disease and frontotemporal lobar degeneration: an eye on microglia.
  Ridolfi E, Barone C, Scarpini E, Galimberti D. Ridolfi E, et al. Clin Dev Immunol. 2013;2013:939786. doi: 10.1155/2013/939786. Epub 2013 Jul 18. Clin Dev Immunol. 2013. PMID: 23970926 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wolters Kluwer

• Medical

  • MedlinePlus Health Information